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Dhara Patel and Palash Mandal
Abstract
Adipose tissue comprises of large volumes of biologically functioning fat glob-
ule, which employs substantial systemic effect. Adipocytes and adipokines play an 
active role in autocrine, paracrine, or endocrine metabolic functions. Recent studies 
demonstrated that the hormonal role of adipocyte and adipose tissue dysfunction 
contributes to the pathogenesis of alcoholic liver disease (ALD) by the activation of 
CYP2E1. The gut microbiome and adipose tissue response play a pivotal role in the 
pathogenesis of ALD. Enteric dysbiosis increases plasma levels of metabolites that 
activate Kupffer cells. Recent literature suggested that chronic alcohol consumption 
is also correlated with oxidative stress in adipose tissue, inflammation, and adipo-
cyte cell death, decrease in adiponectin, increase level of leptin and resistin, adipose 
tissue mass, and insulin resistance that acts on the muscle and liver. Dysbiosis 
combined with non-nutritional diet has an effect on the luminal metabolism caus-
ing immunological changes in the gut that might also contribute to pathogenesis of 
nonalcoholic fatty liver disease (NAFLD). Understanding the interaction between 
the altered gut microbiota, diet, environmental factors, and their effects on the gut-
liver axis can provide an insight toward the pathogenesis of liver-associated disease.
Keywords: alcoholic liver disease, adipose tissue, adipokines, gut microbiota, 
nonalcoholic fatty liver disease
1. Introduction
Alcohol is considered the fifth leading risk factor for premature death and 
various disorders universally. It is psychoactive substance that leads to overuse 
of alcohol or alcoholism abuse. Alcohol related liver diseases are the primary 
cause of every third person undergoing liver transplants worldwide. Worldwide, 
alcohol liver disease (ALD) causes 14.5 million disability-reduced life years and 
approximately 500,000 deaths in 2010 [1]. Depending on behavior, genetics, and 
comorbidities, individuals who consume alcohol develop hepatic steatosis, an early 
stage of alcoholic hepatitis [2]. Although ALD is a disease that requires an intention 
for consumption of alcohol, there are various other factors, including genetic host 
system characteristics involved in the development and progression. The amount of 
pure alcohol consumption and duration is directly linked to cirrhosis.
Adipose tissue comprises of large volumes of biologically functioning fat globule, 
which employs considered to be submissive [3]. Researchers have established a remark-
able understanding of adipocytes being an acute component of metabolic pathways and 
functioning of endocrine organs. Recent studies have given an insight on the hormonal 
role of adipocytes. Adipose tissue is identified to secrete proteins that are termed as 
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adipokines, which play an active role in autocrine, paracrine, or endocrine metabolic 
functions. Adiponectin, leptin, and resistin are the most affected functional adipokines.
The body as a whole is affected on the consumption of alcohol. It has been dem-
onstrated that mainly enteric dysbiosis plays a significant role in the development of 
ALD. Due to an increased intestinal gut permeability of microbes like Clostridiales, 
Ruminococcaceae, and Bifidobacterium spp., this leads to an elevated plasma levels of 
metabolites like lipopolysaccharide (LPS), Toll like receptors (TLR-4, TLR-2), cell 
surface receptor and differentiation marker 14 (CD-14), NADPH oxidase homolog 4 
(Nox-4), glucose transporter-4 (GLUT4), and short-chain fatty acid (SCFA) which 
activates Kupffer cells along with the consequent effects of inflammation, necrosis, 
and oxidative stress. The activation of cytochrome P450 2E1 (CYP2E1) mediated 
by ethanol breakdown leads to adipokine dysfunction. Adiponectin acts as an anti-
inflammatory cytokine while leptin and resistin act as pro-inflammatory cytokines 
that trigger adenosine monophosphate-activated protein kinase (AMPK) pathway 
which activates fatty acid oxidation and decreased hepatic lipid influx and de novo 
lipogenesis. Studies have reported that chronic alcohol consumption leads to reduce 
levels of adiponectin and an increase in leptin secretion and macrophage migration 
inhibitory factor (MIF) leading to reduction in adipose tissue mass and increase in 
fatty acid uptake by hepatocytes [3, 4]. Compounds like rosiglitazone, a PPAR-ϒ ago-
nist that targets the adipocytes exogenously, have shown to attenuate alcohol-induced 
fatty liver [5, 6]. Inflammation due to bacterial translocation is the main contributor 
to the development of alcoholic liver disease. Cytokines like tumor necrosis factor 
alpha (TNF-α), interleukins (IL-1β, IL6, IL8), induced nitric oxide synthase (iNOS), 
reactive oxygen species (ROS), nuclear factor kappa-light-chain-enhancer of acti-
vated B cells (NF-κB), and heme oxygenase (HO-1) increase adipocyte lipolysis and 
systemic insulin resistance by stimulating the release of free fatty acids from adipose 
tissue into the blood stream, which acts on the muscle and liver [4].
The gut microbiome and adipose tissue responses play an essential role in the 
pathogenesis of alcohol liver disease. The mechanism between adipose tissue and 
alcohol consumption is yet to be answered.
2. Adipose tissue
An obese person can have up to 80 L volume of adipose tissue, which contains 
about 24 L volume of biologically active adipose tissue [7, 8]. The factors that affect 
the distribution and volume of adipose tissue mainly vary by gender and location. 
For example, body fat is found more in women than in men. Similarly people from 
southeast Asia have less body fat compared to white people of identical body mass 
index (BMI) [9].
Depending upon the anatomy, adipose tissue is classified as follows:
• Visceral adipose tissue (VAT)
• Subcutaneous adipose tissue (SAT)
Visceral adipose tissue corresponds with insulin resistance and diabetes mel-
litus [10].
2.1 What does adipose tissue composed of ?
Adipocytes are considered to be the building blocks of adipose tissue. Adipocyte 
stores energy from non-esterified fatty acids (NEFA) and esterification of triglyceride 
[11]. Lipotoxicity refers to as uptake of circulating lipids, which prevents accumulation 
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of NEFA in the organs [12]. There are various processes that take place in adipose tissue 
which are controlled by hormonal pathways and are useful for metabolic demand [13]:
• Hydrolysis of triglycerides (lipolysis) takes place during fasting or exercise.
• Synthesis of triglyceride (lipogenesis) takes place during fed state.
2.2 Which cytokines are released by adipocytes?
Adipose tissue secretes adipokines that play a central role in metabolism of 
energy. The secretion of adipokines can be altered due to obesity and insulin resis-
tance. Out of several adipokines, leptin, adiponectin, and resistin are the primary 
ones that are responsible for insulin resistance as well as in ALD [14].
2.3 Different kind of adipokines:
2.3.1 Leptin
Leptin receptor is located in numerous tissues, which controls expenditure of 
energy, food consumption, lipolysis, fatty acid oxidation, lipogenesis, and insulin 
sensitivity signifying as a paracrine and autocrine hormonal function [15]. It also 
helps in enhancing the release of a TNF-α by Kupffer cells [16].
2.3.2 Adiponectin
Adiponectin has a significant role in insulin sensitizing by altering the signal-
ing pathway of AMPK and metabolism of glucose and fatty acid oxidation in 
tissues. It is also responsible for adiopogenesis, prevention of ectopic fat storage 
and decline in Kupffer cell activation [14, 16]. The onset of chronic exposure to 
ethanol can lead to the disruption of adiponectin which is proven to contribute 
toward the imbalance of pro-inflammatory pathways [3]. A preventive study 
was performed on the mice along with the treatment of adiponectin and chronic 
ethanol exposure and signifies the prevention of the liver injury indicating the 
decrease in both steatosis and TNF-α expression in the liver [17]. Though the 
mechanism of the therapeutic adiponectin is not well understood, the hypothesis 
suggests the vital role of a adiponectin in decreasing steatosis which is related to 
glucose and lipid homeostasis [3].
2.3.3 Resistin
Resistin can acquire insulin resistance and regulates food intake, thus acting 
as an antagonist to adiponectin [18]. Resistin, a 12.5-kDa polypeptide, is secreted 
by white adipose tissue in female [19]. In human, resistin gene is mainly found in 
the bone marrow and lung with untraceable levels in adipose tissue [20]. Resistin 
gene expression was provoked during adipocyte differentiation [21]. Thus, serum 
resistin can act as a powerful diagnostic marker to access the severity of liver disease 
and patient with clinical complications [22].
2.3.4 Omentin
Omentin secretion increases insulin sensitivity in adipocytes [16]. It is mainly 
secreted from the stromal vascular fraction of adipose tissue which enhances 
glucose uptake mainly activated by insulin [23]. The concentration of omentin was 
increased in portal vein which is a consistent marker for ALD [24].
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2.3.5 Chemerin
Chemerin helps pre-adipocyte differentiation and contributes to immune cell 
trafficking. It is also proven to increase the sensitivity of insulin as well as provides 
anti-inflammatory effects on endothelium immune cell [25].
2.4 The role of non-adipocytes
Non-adipocyte cells are present in a considerable amount of overall cellularity of 
the adipose tissue. They include cells from perivascular, endothelium, immune, and 
stem cells. These clusters of cells are known as stromal vascular fraction (SVF) [14].
2.4.1 Macrophages as inflammatory mediators
Macrophages make up the majority of the resident immune cells in the adipose 
tissue [26]. The systemic insulin resistance and inflammation are linked with 
increased macrophage infiltration into the adipose tissue indicating M1 pro-inflam-
matory state [27]. “Crown-like structure” is formed where macrophages present in 
adipose tissue encircle dying adipocytes [28]. Adiponectin suppresses macrophage 
activity using several ways; one of them is to prevent proliferation of myelo-
monocytic progenitor cells. This reduces the upregulation of endothelial adhesion 
molecules in response to cytokine production by macrophages [3].
There are other immune cells like B cells, T cells, and dendritic cells which con-
tribute to the obesity-related inflammation. Dendritic cell in particular promotes 
CD4+ T helper cells to activate macrophage recruitment [29]. Neutrophils are seen 
in lean and obese individuals, which are primary defense cells in a high-fructose diet 
mice model [30]. Thus, cytokine expression in adipose tissue is predominately from 
SVF, while in case of obese individuals, there is an increased expression of cyto-
kines [31, 32]. Studies suggested the important link between the adiponectin and 
IL-10, the two main critical anti-inflammatory mediators. For instance, adiponectin 
stimulates IL-10 mRNA and protein expression in RAW264.7 macrophages. In the 
same cells, gAcrp-mediated desensitization to LPS is prevented due to the immuno-
neutralization of IL-10 [3]. HO-1 shows antiproliferative, anti-inflammatory, and 
anti-apoptotic properties. HO-1 is considered as a vital downstream mediator of the 
anti-inflammatory effects of IL-10 in macrophages [33].
3. What is gut microbiota comprised of ?
The human gut contains more than 400 different species, comprising of four 
major bacterial families that play important roles like defining the physiology of the 
host [34]. The majority of mammalian gut microbiota belongs to the two bacterial 
phyla, the gram-negative Bacteroidetes and the gram-positive Firmicutes, which play a 
major role in the maintenance of normal health condition, metabolism, and disease. 
Mainly four major families play an important role, an dthey are comprised of:
• Bacteroidetes
• Firmicutes
• Actinobacteria
• Proteobacteria
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Proximal two thirds of the small intestine and stomach contain less number of 
microbes in the range of 100–104 cfu/ml due to acidic pH. The ileum contains more 
diverse microflora and higher bacterial strains from 107 to 108 cfu/ml. Most amounts 
of species of obligate anaerobe reside in the colon due to a low oxidation-reduction 
potential of the colon. Thus, a subsequent increase in microbes from the stomach 
to colon has been observed, as the human gastrointestinal tract pH has shown 
an increase from the stomach (pH 2.0) to duodenum, jejunum, ileum, and colon 
(pH 5.0–7.0) [35].
Bacteroidetes contain variety of enzymes like hydrolase, dehydrogenase, 
and dehydroxylase that play a major role in the biotransformation of bile acids. 
Firmicutes play an important role in the energy extraction from undigested carbo-
hydrates in the form of production of short-chain fatty acids [36]. Far from being a 
static ecosystem, the content of this phylum radially shifts in the response to change 
in host adiposity and nutrient uptake [37].
Changes in the intake of diet clearly affect composition of an individual’s gut 
microbiota and its body physiology [38]. Complex carbohydrates are metabolized 
by the colonic microorganism. Bifidobacteria convert complex carbohydrates into 
oligosaccharides and monosaccharide, further fermenting into the short-chain 
fatty acid end products like acetate, propionate, and butyrate. Colon absorbs SCFA, 
where butyrate provides energy for colonic epithelial cells; acetate and propionate 
migrate to the liver and other peripheral organs, where they act as substrates for 
gluconeogenesis and lipogenesis [39].
3.1 Gut microflora in well-being, metabolism, and disease
3.1.1 How does gut microflora gets affected in nonalcoholic fatty liver disease?
Nonalcoholic fatty liver disease is the liver disorder whose pathogenesis is not 
well understood due to the portal system interaction with the intestinal lumen and 
liver. Therefore, it is considered that gut microbiome plays an important role in the 
pathogenesis of NAFLD. Also, diet has a potential to modify the gut microbiome 
and several metabolic pathways. Thus, the combination of diet, gut, and liver asso-
ciates directly with the progression of NAFLD or T2D. Most of the diabetic patients 
are diagnosed with high blood glucose levels in context with insulin resistance and 
insulin deficiency.
Westernized diet and pattern of eating are the main driving forces for the 
increased prevalence of insulin resistance and increased obesity. Studies have sug-
gested that the diet rich in saturated fats are directly proportional to weight gain, 
insulin resistance, and hyperlipidemia in humans and animal models [40]. In addi-
tion, diet specifically high in sugars like fructose and sucrose has contributed to the 
metabolic alterations in animal models resulting in weight gain hyperlipidemia and 
hypertension [41]. An overconsumption of fructose hampers glycolysis and glucose 
uptake pathways in the liver. This leads to an enhanced rate of de novo lipogenesis and 
triacylglycerol synthesis leading to insulin resistance through fructose catabolism.
Increased activity of the inflammatory pathways is a very important mechanism 
for insulin resistance. An increase in the activity of the nuclear factor kB (NF-kB) 
pathway and the maintenance of a subacute inflammatory state are associated with 
obesity. These cytokines and chemokine activate intracellular pathways which pro-
mote the development of T2D [42]. Pattern recognition receptors (PRRs) play an 
important role for identification of commensals versus pathogenic microbes, which 
reside in the gastrointestinal tract. TLR recognize extracellular patterns, whereas 
NOD-like receptors (NLRs) recognize intracellular (cytosolic) pathogen Associated 
molecular patterns (PAMPs) [43].
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TLRs, extracellular (innate) pattern recognition receptors, are expressed nearly 
on all the cell types. In total, 13 different TLRs are present in human genome, which 
remain specific for unique class of PAMPs. Among the TLRs, TLR2 and TLR4 are 
considered to be vital for the pathogenesis of insulin resistance and diabetes in both 
clinical and experimental conditions. TLR2 specifically binds to peptidoglycan 
(gram-positive bacteria), and TLR4 binds to lipopolysaccharide (gram-negative 
bacteria) [43]. High-fat or high carbohydrate food intake increases the concentra-
tion of plasma LPS levels and LPS binding protein, which increases the expression 
of TLR2 and TLR4 at mRNA and protein level [44]. The study has also shown that 
the absence of TLR4 protects against the detrimental effects of obesity and lipids 
on the insulin resistance [44]. A study on TLR4 null mice demonstrated a reduced 
adiposity and hepatic steatosis compared with the wild-type control when fed on 
high fat diet (HFD) [45].
NLRs are intracellular or cytoplasmic pattern recognition receptors, which exhibit 
specificity toward one or more PAMPs. In gastrointestinal epithelial cells, nucleotide-
binding oligomerization domain (NOD) is mainly characterized by NLRs. Caspase 
activation and recruitment domain (CARD) is unique for each NOD protein.
• NOD1 (CARD 4): senses peptidoglycan contents in gram-negative bacteria 
specifically meso-diaminopimelic acid (meso-DAP)
• NOD2 (CARD 15): senses muramyl dipeptide, the common molecular motif 
both in gram-positive and gram-negative bacteria.
NOD1 and NOD2 are essential since they were the first NLRs reported as poten-
tial sensors of bacterial components. It has been reported that NOD1 and NOD2 are 
also involved in high fat diet induced-inflammation and insulin intolerance [46]. 
NOD1 agonist causes inflammation and insulin resistance in a primary hepatocytes 
of the wild-type mice, but this effect was absent in NOD1 knockout mice [47].
The downstream pathway that follows after the engagement of NLRs and TLRs 
with their respective ligands leads to the activation of NF-kB-mediated inflammatory 
pathways through adaptor protein MyD88 and secretes the major pro-inflammatory 
cytokines like TNF-α and IL-6. Pro-inflammatory cytokines phosphorylate the serine/
threonine residue of insulin and downregulate the insulin signaling pathway, which 
finally leads to the insulin resistance and occurrence of T2D [48]. In vivo studies in mice 
have shown that the gut tight junction between the cells loosens up when the population 
of Bifidobacteria is decreased. These loose junctions increase the gut permeability and 
allow lipopolysaccharide present in microbes to pass through the gut epithelial resulting 
into metabolic endotoxemia causing a low-grade inflammation which is responsible to 
induce a metabolic disorder including the insulin resistance [49].
Increased body weight with other metabolic phenotypes was observed in the 
germ-free mice who were fed with either low-fat mouse chow or with different 
levels of saturated fat and fruits along with vegetables in different groups [50]. In 
another study, group of mice developed hyperglycemia and high plasma concen-
tration of pro-inflammatory cytokines when HFD was induced. Hyperglycemia 
resulted in hepatic macro-vesicular steatosis, elevated hepatic triglycerides, and de 
novo lipogenesis [51].
When an adult germ-free C57BL/6 mouse was orally fed with normal microbiota 
harvested from the distal intestine of any normal animals, they developed 60% 
increase in body fat content with insulin resistance. Fasting-induced adipocyte 
factor (FIAF), a circulating protein of angiopoietin, is essential for the microbiota-
induced deposition of triglycerides in adipocytes [52]. Deficiency of choline is 
usually liked with NAFLD and nonalcoholic steatohepatitis (NASH) [53].  
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The above-mentioned examples show the significance of the environment and 
genetic factors in correlation with the liver diseases.
3.1.2 How does a whole body responds to alcoholic liver disease?
The liver is a vital organ of the body, as it metabolizes alcohol in three different 
ways as follows:
• By the use of an enzyme alcohol dehydrogenase (ADH)
• By the use of CYP2E1
• By the use of mitochondrial catalase
ADH and CYP2E1 are two significant ways through which alcohol gets con-
verted into acetaldehyde; ADH is used when the consumption of alcohol is limited, 
while on the consumption of an excess alcohol, CYP2E1 metabolism plays a role 
[54]. ADH is not only present in the liver but, it also is expressed in the gastric 
mucosa. It is an assumption that people with lower gastric ADH are more prone to 
the alcoholic liver disease [55].
Alcoholic liver disease includes various stages like alcoholic hepatitis, steatosis, 
steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Alcohol con-
sumption, diet, nutrition, and genetics determine the severity and prognosis of 
ALD. Morbidity and mortality remain higher in the liver cirrhosis than in benign 
liver disease (i.e., liver steatosis) [54]. Twenty percent of the patients with simple 
steatosis with continuous abuse can develop fibrosis within a period of 10 years 
[56]. In an absence of alcohol for a few weeks, simple steatosis is reversible, while a 
fibrogenic process of steatohepatitis can induce cirrhosis. Human trials on revers-
ing the steatohepatitis for the treatment of chronic hepatitis C and NASH are well 
documented [57].
Oxidative stress mainly occurs due to CYP2E1 accompanied along with the 
shortage of antioxidants in the hepatocytes and an altered inflammatory cytokines 
[58]. It has been known that changes in the lipid metabolism and adipose tissue 
will also enhance the process of liver injury [59]. Genetics of an individual is also 
another factor that is taken into account for the susceptibility of alcoholism. Lately 
correlations between the genetic polymorphism of alcoholic metabolizing enzymes 
and ALD have shown a significant association [60]. Family studies in Asian 
population have shown association of the following two genes in particular with 
ALD [61, 62].
• Alcohol dehydrogenase ADH1B*1 allele: responsible for increase in alcohol 
dependence
• Alcohol dehydrogenase ADH2B*2 allele: responsible for decrease in alcohol 
dependence
Diet is also one of the significant factors affecting the structure and functional-
ity of gut microbiota. Alcohol and its degradation products can contribute toward 
the gut dysbiosis [63]. Patients with ALD have shown decrease in commensal 
groups like Roseburia, Faecalibacterium, Blautia, and Bacteroides, while increase in 
Proteobacteria and Bacilli resulting in an increased gut permeability, tight junc-
tion barrier dysfunctioning, and inflammation [64, 65]. One of the proposed 
mechanisms is the direct interaction of gut and endotoxins from the liver via 
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hepatic artery, as well as mechanism of bile acids that contributes toward ALD [66], 
although the mechanism of the latter interaction is yet to be elucidated.
Due to an exposure of alcohol, intestinal microbiome is getting affected by 
causing bacterial (gram negative) overgrowth in animal models and humans. 
Particularly the genus Lactobacillus is on a lower side due to the onset of chronic 
alcohol consumption [67]. It has been recently demonstrated that supplementing 
saturated long-chain fatty acid with commensal Lactobacilli stabilizes the intestinal 
gut barrier and tight junction barrier in ethanol-induced liver disease in mice [68]. 
NOD2 is mainly responsible for increasing bacterial peritonitis and bacterascites in 
cirrhosis, which primarily affects the survival [69]. PAMPs or damage-associated 
molecular patterns (DAMPs) are recognized by inflammasomes and activate the 
pro-inflammatory cytokines such as pro-interleukin (IL-1, IL-18) [70]. Chemokine 
(C-C motif) ligand causes inflammation in colon due to intestinal dysbiosis [71]. 
TNF-receptor-1 (TNFR-1) present on the intestinal epithelial cells are crucial 
mediator for ALD and also cause an intestinal barrier dysbiosis [72]. Thus, inflam-
mation can lead to intestinal permeability, which is associated with the transloca-
tion of microbial products to TLRs in the liver, which is related to aggravated 
hepatic steatosis.
4. Role of immune system in intestinal membrane
Maintaining the balance and symbiotic relation between the immune system and 
host intestinal microbiome is a very important aspect. This is because they main-
tain a balance of an immune system by restricting the overgrowth of pathogenic 
microbiota, as well as the bacteria that reaches the intestinal barriers, chemical 
barriers, and physical barriers [73]. Innate signaling by MyD88 in T cells directs 
IgA-mediated microbiota to promote the healthy gut. In IgA-deficient mice, it has 
been observed that TLR-5 and host protein programmed cell death 1 (PD1) regulate 
the modulation of IgA homeostasis by differentiating B cells into IgA producing 
antibodies [74, 75]. The importance of IgA in the microbiota composition in chronic 
liver disease is yet to be studied.
In liver cirrhosis patient, buccal origin microbes were found in intestine, 
taxonomically signifying the translocation or invasion from mouth to intestine. 
Simultaneously these patients also observed to have compromised innate immune 
system, reduced bile flow and impaired AMP production [76, 77]. The produc-
tion of AMP is mainly regulated by the gut microbiota that includes defensins, 
C-type lectins (Reg3b and Reg3g), ribonucleases, and S100 proteins, which rapidly 
inactivate microbes [78]. In MYD88-deficient mice, NOD2 altered AMP produc-
tion, which was closely marked [79, 80]. Chronic alcohol administration results in 
decreased expression of the intestinal C-type lectins in mice, and similar results 
were observed in the duodenum [81, 82].
Mucin is secreted by the goblet cells which are glycosylated and accountable 
for the construction of the inner and outer layer of mucus. In mice and humans, 
mainly mucin-2 is responsible for the mucus layer formation. Upon interaction 
with the lectin, they are responsible for bacterial composition of the host that 
promotes formation of glycosidase and metabolic enzymes which are used as a 
source of energy [83]. Innate immune system is activated to maintain the intestinal 
homeostasis in the absence of mucin-2. An experiment in the mucin-2-deficient 
mice demonstrated higher expression of antimicrobial proteins and protected the 
intestinal barrier from bacterial overgrowth and dysbiosis. This interconnection 
between the different intestinal defense layers and microbiota helps in decreasing 
ALD [81].
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Interestingly, there is no single assigned bacterial species that marks the begin-
ning or development of the liver disease. It is always marked by an increased 
percentage of gram-negative bacteria especially Proteobacteria which is known for 
accelerating cholestatic liver fibrosis [84]. To study the importance of the intestinal 
microbiota for chronic liver disease, liver fibrosis was induced into the germ-free 
mice model via the administration of thioacetamide in the drinking water. As a 
result in comparison to conventional mice, germ-free mice showed elevated liver 
fibrosis [85].
Ethanol consumptions lead to the elevation of lipopolysaccharide and endotoxin 
in the portal blood circulation that sensitizes Kupffer cells to activate the inflam-
matory mediators like TNF-α, IL6, and ROS. Another factor that facilitates the 
liver disease is the loss of anti-inflammatory mediators. A study has shown IL-10 
deficient mice to be more sensitive to ethanol liver injury [3]. The alterations in the 
intestinal microbiota composition are significant for the pathogenesis of chronic 
liver disease which is demonstrated and briefed in Figure 1.
5. Effect of alcohol on liver and adipose tissue
The energy value of alcohol is equal to those of other nutrients, so when the 
alcohol consumption is increased, the overall calorie intake excessed the expendi-
ture of energy, which leads to adiposity [86]. It has been established that chronic 
cirrhosis patient shifts toward the lipid oxidation instead of carbohydrate as fuel to 
meet the energy requirements which in turn reduces the overall fat mass in an indi-
vidual [87]. Thus, malnutrition with low adipose skeletal muscle mass is a symptom 
for an advancement of the liver disease [88]. Alterations in the body mass may 
also depend on the type of drinking pattern; for instance, a person drinking beer 
or spirits gains more body mass than wine consumption [89]. Thus, excess alcohol 
Figure 1. 
Effect of microbiome dysbiosis on liver disease.
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intake increases the amount of visceral adipose tissue as compared to the changes 
observed in case of obesity [90].
In vivo mice experimental alcoholic model has shown the significant increase in 
the number of adipocyte death in white adipose tissue. The mechanism for death of 
adipocytes involves interaction between CYP2E1, BH3-an interaction domain ago-
nist for death (BID) and C1Q complement pathway. As sequence, these interaction 
lead to adipose tissue inflammation, insulin resistance, lipolysis, NEFA and release 
of proinflammatory cytokines [91]. Hence, increase in uptake of fatty acids in the 
adipose tissue will lead to an increase in hypertrophy, hypoxia, and inflammation 
ultimately leading to the cell death [92]. However, alcohol uptake in the moderation 
has been associated with insulin sensitivity [93]. Thus, acute or chronic alcohol 
consumption is associated with metabolic, endocrine, and immune dysbiosis as 
shown in Figure 2.
5.1 Influence of alcohol on metabolic dysbiosis
Metabolically, an increase of NEFA is seen in ALD patients [94]. Increase in 
NEFA depends on the increase in expression of adipose triglyceride lipase (ATGL) 
but is independent of lipase [95]. Lipolysis is particularly marked by acute alcoholic 
hepatitis (AAH), but it may decrease during the advanced cirrhosis. The molecular 
mechanism that leads to lipolysis with excess ethanol consumption is not clearly 
understood; the possible primary factor may be the ethanol-mediated insulin 
resistance. Contradicting effect is seen with the use of catecholamine, which may 
reduce lipolysis or remain unchanged [96]. Consequently, higher level of circulat-
ing NEFA shows reduced capacity of the adipose tissue to esterify alcohol and store 
up free fatty acid [97]. Further these unsaturated fatty acids are delivered to the 
liver which contributes to hepatic steatosis as they get converted to triglyceride 
[98]. c-Jun N-terminal kinase (JNK) pathway triggers the hepatocyte apoptosis by 
increase in number of saturated fatty acids with enhanced hepatotoxic effect [99]. 
Hepatic de novo lipogenesis increases due to the transcription of sterol regulatory 
Figure 2. 
Association of adipose tissue in alcoholism due to metabolic, endocrine, and immune dysbiosis.
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element-binding protein 1 (Srebf1) [100]. The mechanism that follows in hepa-
tocytes on increase in NEFA activates the hepatic stellate cells (HSCs) which lead 
to the deposition of collagen and fibrosis, which in turn exerts the inflammatory 
pathway through stimulation of NF-ĸB and the activation of Kupffer cells and 
myeloid cells stimulating cytokine release [101].
5.2 Endocrine imbalance due to consumption of alcohol
Acute or chronic alcohol intake has an important difference in both animal and 
human models with respect to the endocrine aspect as shown in Table 1.
Due to the change in an endocrine function, the liver fibrosis takes place by 
promoting HSC activation [108]. Leptin contributes to the activation of TNF-alpha 
and the Kupffer cells, thereby causing hepatic inflammation by stimulating CCL2 
release from HSCs [109]. The administration of adiponectin and recombinant 
adiponectin in ethanol-fed mice reduced the circulating NEFA level as well as 
decreased weight loss, steatosis, and hepatic inflammation due to the inhibition of 
Kupffer cell sensitivity toward LPS [67].
5.3 Immune dysbiosis due to alcohol intake
Oxidative stress due to the consumption of alcohol leads to adipose tissue hypoxia 
which in turn increases the expression of TNF-α, CCL2, IL-6, infiltration of macro-
phages, and expression of CD4+ T cells and dendritic cells in the adipose tissue [110]. 
The secretion of pro-inflammatory cytokines alters the hepatic immunology via 
hepatic inflammation affecting the role of parenchymal and non-parenchymal liver 
cells. TNF-α activation triggers ALD pathogenesis, which induces apoptosis through 
the activation of JNK and NFκB pathways [111]. A protective mechanism of the hepa-
tocytes is exerted by IL-6 through promoting the hepatic survival, proliferation, and 
improved hepatic steatosis [112]. Nevertheless, an excessive exposure of IL-6 can lead 
to the liver carcinogenesis [113]. In CCL2 knockout mice, there is a reduced level of 
hepatic inflammation, proving CCL2 to not play any protective role in hepatic inflam-
mation [114]. The role of CCL2 is much more clear as an inflammatory factor through 
an insulin signaling in NASH, but its role in ALD is yet to be determined [115].
Adipokine In vivo model 
(mouse and 
human)
Acute 
alcoholic 
model
Chronic alcoholic 
model
Reference
Leptin In both models ↓ ↓ [102]
Adiponectin* (high fat diet 
and alcohol)
In human model ↑ ↑ [103]
In mouse model ↑ ↑ [104]
Visfatin In both models ↑ ↑ [105]
Omentin In human model ↑ ↑ [24]
Chemerin In human model ↑ ↑ Chronic alcoholic 
patient
[106]
↓ Cirrhosis patient [107]
*Adiponectin data are in contrast with the observation in individual with obesity and metabolic syndrome due to 
changes in liver function while affecting the bile obstruction.
Table 1. 
The changes in adipokines in mouse and human models with severity of alcohol abuse.
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5.4 Role of microRNA
Exosomes that contain small biologically active but noncoding RNA, i.e., 
microRNA (miRNA), are released by adipocytes which regulate various intracel-
lular processes. These miRNAs are able to temper the distant tissues and organs rep-
resenting the alteration between adipose tissue and liver function as well as immune 
responses [116]. In an animal model, miRNA-122 and miRNA-192 expressions are 
elevated in the ALD, while miRNA-155 expression is increased in the adipose tissues 
in particular, which contributes to the hepatic steatosis and fibrosis [117].
6. Conclusion
Chronic alcohol consumption not only disturbs the metabolism of whole body 
but also has a prominent effect on the function of gut microbiota and adipose 
tissue. These alterations have direct as well as indirect effects on the liver func-
tions, which contribute to the advancement of ALD. Cessation of alcohol intake 
can quickly reverse inflammatory reaction in the adipose tissue and halt the 
progression of ALD. In addition to that, pharmacological treatment can also help 
to improve ALD. There is a significant overlapping in an alteration of the adipose 
tissue between obesity, NAFLD, and ALD mechanism. The physicians who are 
dealing with patients of ALD should keep an eye on the adipose tissue dysfunc-
tion and its effect on the liver and consider the therapeutic treatment accordingly. 
Understanding the fundamental mechanism of the alcohol and metabolic syndrome 
in the pathogenesis of liver disease will help in pursuing an effective treatment for 
liver diseases.
Author details
Dhara Patel and Palash Mandal*
Department of Biological Sciences, P.D. Patel Institute of Applied Sciences, 
Charotar University of Science and Technology, Anand, Gujarat, India
*Address all correspondence to: palashmandal.bio@charusat.ac.in
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
13
Effect of Alcohol on Gut-Liver Axis and Adipose Tissue
DOI: http://dx.doi.org/10.5772/intechopen.89340
References
[1] Rehm J, Samokhvalov AV, Shield KD. 
Global burden of alcoholic liver diseases. 
Journal of Hepatology. 2013;59:160-168. 
DOI: 10.1016/j.jhep.2013.03.007
[2] O’Shea RS, Dasarathy S, 
McCullough AJ, Practice Guideline 
Committee of the American Association 
for the Study of Liver Diseases, Practice 
Parameters Committee of the American 
College of Gastroenterology. Alcoholic 
liver disease. Hepatology. 2010;51: 
307-328. DOI: 10.1002/hep.23258
[3] Mandal P, Park P-H, McMullen MR, 
Pratt BT, Nagy LE. The anti-
inflammatory effects of adiponectin 
are mediated via a heme oxygenase-1-
dependent pathway in rat Kupffer cells. 
Hepatology. 2010;51:1420-1429. DOI: 
10.1002/hep.23427
[4] Steiner J, Lang C. Alcohol, adipose 
tissue and lipid dysregulation. 
Biomolecules. 2017;7:16. DOI: 10.3390/
biom7010016
[5] Sun X, Tang Y, Tan X, Li Q , 
Zhong W, Sun X, et al. Activation of 
peroxisome proliferator-activated 
receptor-γ by rosiglitazone improves 
lipid homeostasis at the adipose 
tissue-liver axis in ethanol-fed mice. 
American Journal of Physiology. 
Gastrointestinal and Liver Physiology. 
2012;302:G548-G557. DOI: 10.1152/
ajpgi.00342.2011
[6] Zhang W, Zhong W, Sun X, Sun Q ,  
Tan X, Li Q , et al. Visceral white 
adipose tissue is susceptible to alcohol-
induced lipodystrophy in rats: Role of 
acetaldehyde. Alcoholism, Clinical and 
Experimental Research. 2015;39: 
416-423. DOI: 10.1111/acer.12646
[7] Molina DK, DiMaio VJM. Normal 
organ weights in women. The American 
Journal of Forensic Medicine and 
Pathology. 2015;36:176-181. DOI: 
10.1097/PAF.0000000000000174
[8] Molina DK, DiMaio VJM. Normal 
organ weights in men. The American 
Journal of Forensic Medicine and 
Pathology. 2012;33:368-372. DOI: 
10.1097/PAF.0b013e31823d29ad
[9] Nazare J-A, Smith JD, Borel A-L, 
Haffner SM, Balkau B, Ross R, et al. 
Ethnic influences on the relations between 
abdominal subcutaneous and visceral 
adiposity, liver fat, and cardiometabolic 
risk profile: The international study of 
prediction of intra-abdominal adiposity 
and its relationship with cardiometabolic 
risk/intra-abdominal adiposity. The 
American Journal of Clinical Nutrition. 
2012;96:714-726. DOI: 10.3945/
ajcn.112.035758
[10] Raji A, Seely EW, Arky RA, 
Simonson DC. Body fat distribution 
and insulin resistance in healthy Asian 
Indians and Caucasians. The Journal of 
Clinical Endocrinology and Metabolism. 
2001;86:5366-5371. DOI: 10.1210/
jcem.86.11.7992
[11] Rutkowski JM, Stern JH, 
Scherer PE. The cell biology of fat 
expansion. The Journal of Cell Biology. 
2015;208:501-512. DOI: 10.1083/
jcb.201409063
[12] Cusi K. Role of obesity and 
lipotoxicity in the development 
of nonalcoholic steatohepatitis: 
Pathophysiology and clinical 
implications. Gastroenterology. 
2012;142:711-725. DOI: 10.1053/j.
gastro.2012.02.003
[13] Nielsen TS, Jessen N, Jorgensen JOL, 
Moller N, Lund S. Dissecting adipose 
tissue lipolysis: Molecular regulation 
and implications for metabolic disease. 
Journal of Molecular Endocrinology. 
2014;52:R199-R222. DOI: 10.1530/
JME-13-0277
[14] Patel D, Patel F, Mandal P. 
Potential molecular mechanism of 
Adipose Tissue - An Update
14
probiotics in alcoholic liver disease. 
Journal of Alcoholism and Drug 
Dependence. 2017;5:1-11. DOI: 
10.4172/2329-6488.1000278
[15] Stern JH, Rutkowski JM, Scherer PE. 
Adiponectin, leptin, and fatty acids 
in the maintenance of metabolic 
homeostasis through adipose tissue 
crosstalk. Cell Metabolism. 2016;23: 
770-784. DOI: 10.1016/j.
cmet.2016.04.011
[16] Parker R, Kim S-J, Gao B. Alcohol, 
adipose tissue and liver disease: 
Mechanistic links and clinical 
considerations. Nature Reviews. 
Gastroenterology & Hepatology. 
2017;15:50-59. DOI: 10.1038/
nrgastro.2017.116
[17] Xu A, Wang Y, Keshaw H, Xu LY, 
Lam KSL, Cooper GJS. The fat-derived 
hormone adiponectin alleviates 
alcoholic and nonalcoholic fatty liver 
diseases in mice. The Journal of Clinical 
Investigation. 2003;112:91-100. DOI: 
10.1172/JCI17797
[18] Vázquez MJ, González CR, 
Varela L, Lage R, Tovar S, 
Sangiao-Alvarellos S, et al. Central 
resistin regulates hypothalamic 
and peripheral lipid metabolism in 
a nutritional-dependent fashion. 
Endocrinology. 2008;149:4534-4543. 
DOI: 10.1210/en.2007-1708
[19] Pravdova E, Fickova M. Alcohol 
intake modulates hormonal activity of 
adipose tissue. Endocrine Regulations. 
2006;40:91-104
[20] Patel L, Buckels AC, Kinghorn IJ, 
Murdock PR, Holbrook JD, Plumpton C, 
et al. Resistin is expressed in human 
macrophages and directly regulated 
by PPAR gamma activators. 
Biochemical and Biophysical Research 
Communications. 2003;300:472-476
[21] Steppan CM, Bailey ST, Bhat S, 
Brown EJ, Banerjee RR, Wright CM, 
et al. The hormone resistin links obesity 
to diabetes. Nature. 2001;409:307-312. 
DOI: 10.1038/35053000
[22] Yagmur E, Trautwein C, 
Gressner AM, Tacke F. Resistin serum 
levels are associated with insulin 
resistance, disease severity, clinical 
complications, and prognosis in 
patients with chronic liver diseases. The 
American Journal of Gastroenterology. 
2006;101:1244-1252. DOI: 
10.1111/j.1572-0241.2006.00543.x
[23] Yang R-Z, Lee M-J, Hu H, Pray J,  
Wu H-B, Hansen BC, et al. Identification 
of omentin as a novel depot-specific 
adipokine in human adipose tissue: 
Possible role in modulating insulin 
action. American Journal of Physiology. 
Endocrinology and Metabolism. 
2006;290:E1253-E1261. DOI: 10.1152/
ajpendo.00572.2004
[24] Eisinger K, Krautbauer S, Wiest R, 
Karrasch T, Hader Y, Scherer MN, et al. 
Portal vein omentin is increased in 
patients with liver cirrhosis but is not 
associated with complications of portal 
hypertension. European Journal of 
Clinical Investigation. 2013;43:926-932. 
DOI: 10.1111/eci.12122
[25] Ernst MC, Sinal CJ. Chemerin: At 
the crossroads of inflammation and 
obesity. Trends in Endocrinology and 
Metabolism. 2010;21:660-667. DOI: 
10.1016/j.tem.2010.08.001
[26] Weisberg SP, McCann D, 
Desai M, Rosenbaum M, Leibel RL, 
Ferrante AW. Obesity is associated 
with macrophage accumulation in 
adipose tissue. The Journal of Clinical 
Investigation. 2003;112:1796-1808.  
DOI: 10.1172/JCI19246
[27] Lumeng CN, Bodzin JL, 
Saltiel AR. Obesity induces a phenotypic 
switch in adipose tissue macrophage 
polarization. The Journal of Clinical 
Investigation. 2007;117:175-184.  
DOI: 10.1172/JCI29881
15
Effect of Alcohol on Gut-Liver Axis and Adipose Tissue
DOI: http://dx.doi.org/10.5772/intechopen.89340
[28] Lumeng CN, DelProposto JB, 
Westcott DJ, Saltiel AR. Phenotypic 
switching of adipose tissue 
macrophages with obesity is generated 
by spatiotemporal differences in 
macrophage subtypes. Diabetes. 
2008;57:3239-3246. DOI: 10.2337/
db08-0872
[29] Stefanovic-Racic M, Yang X, 
Turner MS, Mantell BS, Stolz DB, 
Sumpter TL, et al. Dendritic cells 
promote macrophage infiltration and 
comprise a substantial proportion 
of obesity-associated increases in 
CD11c+ cells in adipose tissue and liver. 
Diabetes. 2012;61:2330-2339. DOI: 
10.2337/db11-1523
[30] Elgazar-Carmon V, Rudich A, 
Hadad N, Levy R. Neutrophils 
transiently infiltrate intra-abdominal 
fat early in the course of high-fat 
feeding. Journal of Lipid Research. 
2008;49:1894-1903. DOI: 10.1194/jlr.
M800132-JLR200
[31] Xu H, Barnes GT, Yang Q , 
Tan G, Yang D, Chou CJ, et al. Chronic 
inflammation in fat plays a crucial role 
in the development of obesity-related 
insulin resistance. The Journal of 
Clinical Investigation. 2003;112: 
1821-1830. DOI: 10.1172/JCI19451
[32] Fain JN. Release of interleukins 
and other inflammatory cytokines 
by human adipose tissue is enhanced 
in obesity and primarily due to the 
nonfat cells. Vitamins and Hormones. 
2006;74:443-477. DOI: 10.1016/
S0083-6729(06)74018-3
[33] Otterbein LE, Soares MP, 
 Yamashita K, Bach FH. Heme 
oxygenase-1: Unleashing the protective 
properties of heme. Trends in 
Immunology. 2003;24:449-455
[34] Nicholson JK, Holmes E,  
Wilson ID. Opinion: Gut 
microorganisms, mammalian 
metabolism and personalized health 
care. Nature Reviews. Microbiology. 
2005;3:431-438. DOI: 10.1038/
nrmicro1152
[35] Sekirov I, Russell SL, Antunes LCM, 
Finlay BB. Gut microbiota in health 
and disease. Physiological Reviews. 
2010;90:859-904. DOI: 10.1152/
physrev.00045.2009
[36] Guarner F, Malagelada J-R. Gut 
flora in health and disease. Lancet. 
2003;361:512-519. DOI: 10.1016/
S0140-6736(03)12489-0
[37] Ley RE, Turnbaugh PJ, Klein S, 
Gordon JI. Microbial ecology: Human 
gut microbes associated with obesity. 
Nature. 2006;444:1022-1023. DOI: 
10.1038/4441022a
[38] Flint HJ, Scott KP, Louis P, 
Duncan SH. The role of the gut 
microbiota in nutrition and health. 
Nature Reviews. Gastroenterology 
& Hepatology. 2012;9:577-589. DOI: 
10.1038/nrgastro.2012.156
[39] Cani PD, Delzenne NM. The 
role of the gut microbiota in energy 
metabolism and metabolic disease. 
Current Pharmaceutical Design. 
2009;15:1546-1558
[40] Kootte RS, Vrieze A, Holleman F, 
Dallinga-Thie GM, Zoetendal EG, de 
Vos WM, et al. The therapeutic 
potential of manipulating gut 
microbiota in obesity and type 2 
diabetes mellitus. Diabetes, Obesity 
and Metabolism. 2012;14:112-120. DOI: 
10.1111/j.1463-1326.2011.01483.x
[41] Vrieze A, Holleman F, Zoetendal EG, 
de Vos WM, Hoekstra JBL, 
Nieuwdorp M. The environment within: 
How gut microbiota may influence 
metabolism and body composition. 
Diabetologia. 2010;53:606-613. DOI: 
10.1007/s00125-010-1662-7
[42] Shoelson SE, Lee J, Goldfine AB. 
Inflammation and insulin resistance. 
Adipose Tissue - An Update
16
The Journal of Clinical Investigation. 
2006;116:1793-1801. DOI: 10.1172/
JCI29069
[43] Takeuchi O, Akira S. Pattern 
recognition receptors and inflammation. 
Cell. 2010;140:805-820. DOI: 10.1016/j.
cell.2010.01.022
[44] Shi H, Kokoeva MV, Inouye K, 
Tzameli I, Yin H, Flier JS. TLR4 links 
innate immunity and fatty acid–induced 
insulin resistance. The Journal of 
Clinical Investigation. 2006;116: 
3015-3025. DOI: 10.1172/JCI28898
[45] Kaushik RS, George S, Circle K, 
Lindblom S, Vilain S, Rosa AJM, et al. 
Assessment of toll-like receptors in 
the ileum of weanling pigs-responses 
to feed antibiotic chlortetracycline 
and gnotobiotic conditions. 
Journal of Clinical and Cellular 
Immunology. 2012;3:125. DOI: 
10.4172/2155-9899.1000125
[46] Schertzer JD, Tamrakar AK, 
Magalhaes JG, Pereira S, Bilan PJ, 
Fullerton MD, et al. NOD1 activators 
link innate immunity to insulin 
resistance. Diabetes. 2011;60:2206-2215. 
DOI: 10.2337/db11-0004
[47] Zhao L, Hu P, Zhou Y, Purohit J, 
Hwang D. NOD1 activation induces 
proinflammatory gene expression 
and insulin resistance in 3T3-L1 
adipocytes. American Journal 
Physiology Endocrinology Metabolism. 
2011;301:E587-E598. DOI: 10.1152/
ajpendo.00709.2010
[48] Basciano H, Federico L, Adeli K. 
Fructose, insulin resistance, and 
metabolic dyslipidemia. Nutrition & 
Metabolism (London). 2005;2:5. DOI: 
10.1186/1743-7075-2-5
[49] Cani PD, Delzenne NM. Interplay 
between obesity and associated 
metabolic disorders: New insights into 
the gut microbiota. Current Opinion in 
Pharmacology. 2009;9:737-743. DOI: 
10.1016/j.coph.2009.06.016
[50] Ridaura VK, Faith JJ, Rey FE, 
Cheng J, Duncan AE, Kau AL, et al. 
Gut microbiota from twins discordant 
for obesity modulate metabolism in 
mice. Science. 2013;341:1241214. DOI: 
10.1126/science.1241214
[51] Turnbaugh PJ, Ley RE, 
Mahowald MA, Magrini V, Mardis ER, 
Gordon JI. An obesity-associated gut 
microbiome with increased capacity for 
energy harvest. Nature. 2006;444: 
1027-1131. DOI: 10.1038/nature05414
[52] Backhed F, Ding H, Wang T, 
Hooper LV, Koh GY, Nagy A, et al. The 
gut microbiota as an environmental 
factor that regulates fat storage. 
Proceedings of the National Academy of 
Sciences. 2004;101:15718-15723. DOI: 
10.1073/pnas.0407076101
[53] Spencer MD, Hamp TJ, Reid RW, 
Fischer LM, Zeisel SH, Fodor AA. 
Association between composition of 
the human gastrointestinal microbiome 
and development of fatty liver with 
choline deficiency. Gastroenterology. 
2011;140:976-986. DOI: 10.1053/j.
gastro.2010.11.049
[54] Bruha R, Dvorak K, Petrtyl J. 
Alcoholic liver disease. World Journal 
of Hepatology. 2012;4:81-90. DOI: 
10.4254/wjh.v4.i3.81
[55] Frezza M, di Padova C, Pozzato G, 
Terpin M, Baraona E, Lieber CS. High 
blood alcohol levels in women. The 
New England Journal of Medicine. 
1990;322:95-99. DOI: 10.1056/
NEJM199001113220205
[56] Teli MR, James OF, Burt AD, 
Bennett MK, Day CP. The natural 
history of nonalcoholic fatty liver: 
A follow-up study. Hepatology. 
1995;22:1714-1719
[57] Poynard T, Mchutchison J, 
Manns M, Trepo C, Lindsay K, 
Goodman Z, et al. Impact of pegylated 
interferon alfa-2b and ribavirin on 
17
Effect of Alcohol on Gut-Liver Axis and Adipose Tissue
DOI: http://dx.doi.org/10.5772/intechopen.89340
liver fibrosis in patients with chronic 
hepatitis C. Gastroenterology. 
2002;122(5):1303-1313. DOI: 10.1053/
gast.2002.33023
[58] Yin M, Wheeler MD, Kono H, 
Bradford BU, Gallucci RM, Luster MI, 
et al. Essential role of tumor necrosis 
factor alpha in alcohol-induced liver 
injury in mice. Gastroenterology. 
1999;117:942-952
[59] Donohue TM. Alcohol-induced 
steatosis in liver cells. World Journal of 
Gastroenterology. 2007;13:4974-4978. 
DOI: 10.3748/WJG.V13.I37.4974
[60] Juran BD, Lazaridis KN. Concise 
review in mechanisms of disease 
genomics and complex liver disease: 
Challenges and opportunities. 
Hepatology. 2006;44(6):1380-1390. 
DOI: 10.1002/hep.21453
[61] Whitfield JB. Meta-analysis of 
the effects of alcohol dehydrogenase 
genotype on alcohol dependence and 
alcoholic liver disease. Alcohol and 
Alcoholism. 1997;32:613-619
[62] Thomasson HR, Crabb DW, 
Edenberg HJ, Li TK, Hwu HG, Chen CC, 
et al. Low frequency of the ADH2*2 
allele among Atayal natives of Taiwan 
with alcohol use disorders. Alcoholism, 
Clinical and Experimental Research. 
1994;18:640-643
[63] Dubinkina VB, Tyakht AV, 
Odintsova VY, Yarygin KS, 
Kovarsky BA, Pavlenko AV, et al. 
Links of gut microbiota composition 
with alcohol dependence syndrome 
and alcoholic liver disease. 
Microbiome. 2017;5:141. DOI: 10.1186/
s40168-017-0359-2
[64] Bull-Otterson L, Feng W, 
Kirpich I, Wang Y, Qin X, Liu Y, et al. 
Metagenomic analyses of alcohol 
induced pathogenic alterations in the 
intestinal microbiome and the effect of 
lactobacillus rhamnosus GG treatment. 
PLoS One. 2013;8:e53028. DOI: 10.1371/
journal.pone.0053028
[65] Mutlu EA, Gillevet PM, 
Rangwala H, Sikaroodi M, Naqvi A, 
Engen PA, et al. Colonic microbiome is 
altered in alcoholism. American Journal 
of Physiology. Gastrointestinal and 
Liver Physiology. 2012;302:G966-G978. 
DOI: 10.1152/ajpgi.00380.2011
[66] Ridlon JM, Kang D-J, Hylemon PB, 
Bajaj JS. Gut microbiota, cirrhosis, and 
alcohol regulate bile acid metabolism in 
the gut. Digestive Diseases. 2015;33: 
338-345. DOI: 10.1159/000371678
[67] Leclercq S, Matamoros S, Cani PD, 
Neyrinck AM, Jamar F, Stärkel P, et al. 
Intestinal permeability, gut-bacterial 
dysbiosis, and behavioral markers 
of alcohol-dependence severity. 
Proceedings of the National Academy of 
Sciences. 2014;111:E4485-E4493. DOI: 
10.1073/pnas.1415174111
[68] Llorente C, Schnabl B. The gut 
microbiota and liver disease. Cellular 
and Molecular Gastroenterology and 
Hepatology. 2015;1:275-284. DOI: 
10.1016/j.jcmgh.2015.04.003
[69] Bruns T, Peter J, Reuken PA, 
Grabe DH, Schuldes SR, Brenmoehl J, 
et al. NOD2 gene variants are a risk 
factor for culture-positive spontaneous 
bacterial peritonitis and monomicrobial 
bacterascites in cirrhosis. Liver 
International. 2012;32:223-230. DOI: 
10.1111/j.1478-3231.2011.02561.x
[70] Saner FH, Nowak K, Hoyer D, 
Rath P, Canbay A, Paul A, et al. A non-
interventional study of the genetic 
polymorphisms of NOD2 associated 
with increased mortality in non-
alcoholic liver transplant patients. BMC 
Gastroenterology. 2014;14:4. DOI: 
10.1186/1471-230X-14-4
[71] Henao-Mejia J, Elinav E, Jin C, 
Hao L, Mehal WZ, Strowig T, et al. 
Inflammasome-mediated dysbiosis 
Adipose Tissue - An Update
18
regulates progression of NAFLD and 
obesity. Nature. 2012;482:179-185. DOI: 
10.1038/nature10809
[72] Chen P, Stärkel P, Turner JR, 
Ho SB, Schnabl B. Dysbiosis-induced 
intestinal inflammation activates 
tumor necrosis factor receptor I and 
mediates alcoholic liver disease in mice. 
Hepatology. 2015;61:883-894. DOI: 
10.1002/hep.27489
[73] Swidsinski A, Sydora BC, Doerffel Y, 
Loening-Baucke V, Vaneechoutte M, 
Lupicki M, et al. Viscosity gradient 
within the mucus layer determines 
the mucosal barrier function and the 
spatial organization of the intestinal 
microbiota. Inflammatory Bowel 
Diseases. 2007;13:963-970. DOI: 
10.1002/ibd.20163
[74] Macpherson AJ, Gatto D, 
Sainsbury E, Harriman GR, 
Hengartner H, Zinkernagel RM. 
A primitive T cell-independent 
mechanism of intestinal mucosal IgA 
responses to commensal bacteria. 
Science. 2000;288:2222-2226
[75] Kawamoto S, Tran TH, Maruya M, 
Suzuki K, Doi Y, Tsutsui Y, et al. The 
inhibitory receptor PD-1 regulates IgA 
selection and bacterial composition 
in the gut. Science. 2012;336:485-489. 
DOI: 10.1126/science.1217718
[76] Teltschik Z, Wiest R, 
Beisner J, Nuding S, Hofmann C, 
Schoelmerich J, et al. Intestinal 
bacterial translocation in rats with 
cirrhosis is related to compromised 
paneth cell antimicrobial host defense. 
Hepatology. 2012;55:1154-1163. DOI: 
10.1002/hep.24789
[77] Lu H, Wu Z, Xu W, Yang J, Chen Y, 
Li L. Intestinal microbiota was assessed 
in cirrhotic patients with hepatitis B 
virus infection. Microbial Ecology. 
2011;61:693-703. DOI: 10.1007/
s00248-010-9801-8
[78] Yang D, Chertov O, Oppenheim JJ. 
Participation of mammalian defensins 
and cathelicidins in anti-microbial 
immunity: Receptors and activities 
of human defensins and cathelicidin 
(LL-37). Journal of Leukocyte Biology. 
2001;69:691-697
[79] Petnicki-Ocwieja T, Hrncir T, 
Liu Y-J, Biswas A, Hudcovic T, 
Tlaskalova-Hogenova H, et al. Nod2 
is required for the regulation of 
commensal microbiota in the intestine. 
Proceedings of the National Academy of 
Sciences. 2009;106:15813-15818. DOI: 
10.1073/pnas.0907722106
[80] Vaishnava S, Yamamoto M, 
Severson KM, Ruhn KA, Yu X, 
Koren O, et al. The antibacterial lectin 
RegIIIgamma promotes the spatial 
segregation of microbiota and host in 
the intestine. Science. 2011;334:255-258. 
DOI: 10.1126/science.1209791
[81] Hartmann P, Chen P, Wang HJ, 
Wang L, McCole DF, Brandl K, et al. 
Deficiency of intestinal mucin-2 
ameliorates experimental alcoholic 
liver disease in mice. Hepatology. 
2013;58:108-119. DOI: 10.1002/
hep.26321
[82] Yan AW, Fouts DE, Brandl J, 
Stärkel P, Torralba M, Schott E, et al. 
Enteric dysbiosis associated with a 
mouse model of alcoholic liver disease. 
Hepatology. 2011;53:96-105. DOI: 
10.1002/hep.24018
[83] Derrien M, van Passel MW, van 
de Bovenkamp JH, Schipper RG, de 
Vos WM, Dekker J. Mucin-bacterial 
interactions in the human oral cavity 
and digestive tract. Gut Microbes. 
2010;1:254-268. DOI: 10.4161/
gmic.1.4.12778
[84] De Minicis S, Rychlicki C, 
Agostinelli L, Saccomanno S, 
Candelaresi C, Trozzi L, et al. Dysbiosis 
contributes to fibrogenesis in the 
19
Effect of Alcohol on Gut-Liver Axis and Adipose Tissue
DOI: http://dx.doi.org/10.5772/intechopen.89340
course of chronic liver injury in mice. 
Hepatology. 2014;59:1738-1749. DOI: 
10.1002/hep.26695
[85] Mazagova M, Wang L, Anfora AT, 
Wissmueller M, Lesley SA, 
Miyamoto Y, et al. Commensal 
microbiota is hepatoprotective and 
prevents liver fibrosis in mice. The 
FASEB Journal. 2015;29:1043-1055. DOI: 
10.1096/fj.14-259515
[86] Mitchell MC, Herlong HF. Alcohol 
and nutrition: Caloric value, 
bioenergetics, and relationship to liver 
damage. Annual Review of Nutrition. 
1986;6:457-474. DOI: 10.1146/annurev.
nu.06.070186.002325
[87] Levine JA, Harris MM, Morgan MY. 
Energy expenditure in chronic alcohol 
abuse. European Journal of Clinical 
Investigation. 2000;30:779-786
[88] Pirlich M, Schutz T, Spachos T, 
Ertl S, Weis M, Lochs H, et al. 
Bioelectrical impedance analysis is 
a useful bedside technique to assess 
malnutrition in cirrhotic patients 
with and without ascites. Hepatology. 
2000;32:1208-1215. DOI: 10.1053/
jhep.2000.20524
[89] Sayon-Orea C, Bes-Rastrollo M, 
Nuñez-Cordoba JM, Basterra-Gortari FJ, 
Beunza JJ, Martinez-Gonzalez MA. Type 
of alcoholic beverage and incidence of 
overweight/obesity in a Mediterranean 
cohort: The SUN project. Nutrition. 
2011;27:802-808. DOI: 10.1016/j.
nut.2010.08.023
[90] Molenaar EA, Massaro JM, 
Jacques PF, Pou KM, Ellison RC, 
Hoffmann U, et al. Association of lifestyle 
factors with abdominal subcutaneous 
and visceral adiposity: The Framingham 
Heart Study. Diabetes Care. 2009;32: 
505-510. DOI: 10.2337/dc08-1382
[91] Sebastian BM, Roychowdhury S, 
Tang H, Hillian AD, Feldstein AE, 
Stahl GL, et al. Identification of a 
cytochrome P4502E1/bid/C1q-dependent 
axis mediating inflammation in adipose 
tissue after chronic ethanol feeding 
to mice. The Journal of Biological 
Chemistry. 2011;286:35989-35997. DOI: 
10.1074/jbc.M111.254201
[92] Sun K, Kusminski CM, Scherer PE. 
Adipose tissue remodeling and obesity. 
The Journal of Clinical Investigation. 
2011;121:2094-2101. DOI: 10.1172/
JCI45887
[93] Goude D, Fagerberg B, Hulthe J, AIR 
Study Group. Alcohol consumption, 
the metabolic syndrome and insulin 
resistance in 58-year-old clinically 
healthy men (AIR study). Clinical 
Science (London, England). 
2002;102:345-352. DOI: 10.1042/
CS1020345
[94] Rachakonda V, Gabbert C, 
Raina A, Li H, Malik S, DeLany JP, et al. 
Stratification of risk of death in severe 
acute alcoholic hepatitis using a panel of 
adipokines and cytokines. Alcoholism, 
Clinical and Experimental Research. 
2014;38:2712-2721. DOI: 10.1111/
acer.12558
[95] Zhong W, Zhao Y, Tang Y, Wei X, 
Shi X, Sun W, et al. Chronic alcohol 
exposure stimulates adipose tissue 
lipolysis in mice. The American Journal 
of Pathology. 2012;180:998-1007. DOI: 
10.1016/j.ajpath.2011.11.017
[96] Kang L, Nagy LE. Chronic ethanol 
feeding suppresses beta-adrenergic 
receptor-stimulated lipolysis in 
adipocytes isolated from epididymal fat. 
Endocrinology. 2006;147:4330-4338. 
DOI: 10.1210/en.2006-0120
[97] Liangpunsakul S, Bennett R, 
Westerhold C, Ross RA, Crabb DW, 
Lai X, et al. Increasing serum pre-
adipocyte factor-1 (Pref-1) correlates 
with decreased body fat, increased free 
fatty acids, and level of recent alcohol 
Adipose Tissue - An Update
20
consumption in excessive alcohol 
drinkers. Alcohol. 2014;48:795-800. 
DOI: 10.1016/j.alcohol.2014.07.013
[98] Wei X, Shi X, Zhong W, Zhao Y, 
Tang Y, Sun W, et al. Chronic alcohol 
exposure disturbs lipid homeostasis at the 
adipose tissue-liver axis in mice: Analysis 
of triacylglycerols using high-resolution 
mass spectrometry in combination with 
In vivo metabolite deuterium labeling. 
PLoS One. 2013;8:e55382. DOI: 10.1371/
journal.pone.0055382
[99] Malhi H, Bronk SF, Werneburg NW, 
Gores GJ. Free fatty acids induce JNK-
dependent hepatocyte lipoapoptosis. 
The Journal of Biological Chemistry. 
2006;281:12093-12101. DOI: 10.1074/
jbc.M510660200
[100] Siler SQ , Neese RA, 
Hellerstein MK. De novo lipogenesis, 
lipid kinetics, and whole-body lipid 
balances in humans after acute alcohol 
consumption. The American Journal of 
Clinical Nutrition. 1999;70:928-936
[101] Boden G, She P, Mozzoli M, 
Cheung P, Gumireddy K, Reddy P, 
et al. Free fatty acids produce insulin 
resistance and activate the 
proinflammatory nuclear factor-
kappaB pathway in rat liver. Diabetes. 
2005;54:3458-3465
[102] Nicolas J, Fernández-Solà J. 
Increased circulating leptin levels 
in chronic alcoholism. Alcoholism, 
Clinical and Experimental Research. 
2001;25(1):83-88
[103] Tang H, Sebastian BM, Axhemi A, 
Chen X, Hillian AD, Jacobsen DW, 
et al. Ethanol-induced oxidative stress 
via the CYP2E1 pathway disrupts 
adiponectin secretion from adipocytes. 
Alcoholism, Clinical and Experimental 
Research. 2012;36:214-222. DOI: 
10.1111/j.1530-0277.2011.01607.x
[104] Xu J, Lai KKY, Verlinsky A, 
Lugea A, French SW, Cooper MP, et al. 
Synergistic steatohepatitis by 
moderate obesity and alcohol in mice 
despite increased adiponectin and 
p-AMPK. Journal of Hepatology. 
2011;55:673-682. DOI: 10.1016/j.
jhep.2010.12.034
[105] Czarnecki D, Rosińska Z, 
Żekanowska E, Ziółkowski M, 
Góralczyk B, Gorzelańczyk EJ, et al. 
Changes in concentration of visfatin 
during four weeks of inpatient 
treatment of alcohol dependent males. 
Alcoholism and Drug Addiction. 
2015;28:173-181. DOI: 10.1016/j.
alkona.2015.05.002
[106] Ren R-Z, Zhang X, Xu J, Zhang 
H-Q , Yu C-X, Cao M-F, et al. Chronic 
ethanol consumption increases the 
levels of chemerin in the serum and 
adipose tissue of humans and rats. Acta 
Pharmacologica Sinica. 2012;33:652-659. 
DOI: 10.1038/aps.2012.11
[107] Eisinger K, Krautbauer S, Wiest R, 
Weiss TS, Buechler C. Reduced serum 
chemerin in patients with more severe 
liver cirrhosis. Experimental and 
Molecular Pathology. 2015;98:208-213. 
DOI: 10.1016/j.yexmp.2015.01.010
[108] Ikejima K, Honda H, Yoshikawa M, 
Hirose M, Kitamura T, Takei Y, et al. 
Leptin augments inflammatory and 
profibrogenic responses in the murine 
liver induced by hepatotoxic chemicals. 
Hepatology. 2001;34:288-297. DOI: 
10.1053/jhep.2001.26518
[109] Shen J, Sakaida I, Uchida K, 
Terai S, Okita K. Leptin enhances TNF-α 
production via p38 and JNK MAPK 
in LPS-stimulated Kupffer cells. Life 
Sciences. 2005;77:1502-1515. DOI: 
10.1016/j.lfs.2005.04.004
[110] Voican CS, Njiké-Nakseu M, 
Boujedidi H, Barri-Ova N, 
Bouchet-Delbos L, Agostini H, et al. 
Alcohol withdrawal alleviates adipose 
tissue inflammation in patients 
with alcoholic liver disease. Liver 
21
Effect of Alcohol on Gut-Liver Axis and Adipose Tissue
DOI: http://dx.doi.org/10.5772/intechopen.89340
International. 2015;35:967-978. DOI: 
10.1111/liv.12575
[111] Schwabe RF, Brenner DA. 
Mechanisms of liver injury. I. TNF-
α-induced liver injury: Role of 
IKK, JNK, and ROS pathways. The 
American Journal of Physiology-
Gastrointestinal and Liver Physiology. 
2006;290:G583-G589. DOI: 10.1152/
ajpgi.00422.2005
[112] Hong F, Radaeva S, Pan H, Tian Z, 
Veech R, Gao B. Interleukin 6 alleviates 
hepatic steatosis and ischemia/
reperfusion injury in mice with fatty 
liver disease. Hepatology. 2004;40: 
933-941. DOI: 10.1002/hep.20400
[113] Park EJ, Lee JH, Yu G-Y, He G, 
Ali SR, Holzer RG, et al. Dietary and 
genetic obesity promote liver 
inflammation and tumorigenesis by 
enhancing IL-6 and TNF expression. 
Cell. 2010;140:197-208. DOI: 10.1016/j.
cell.2009.12.052
[114] Mandrekar P, Ambade A, Lim A, 
Szabo G, Catalano D. An essential 
role for monocyte chemoattractant 
protein-1 in alcoholic liver injury: 
Regulation of proinflammatory 
cytokines and hepatic steatosis in mice. 
Hepatology. 2011;54:2185-2197. DOI: 
10.1002/hep.24599
[115] Nio Y, Yamauchi T, Iwabu M, 
Okada-Iwabu M, Funata M, 
Yamaguchi M, et al. Monocyte 
chemoattractant protein-1 (MCP-1) 
deficiency enhances alternatively 
activated M2 macrophages and 
ameliorates insulin resistance and 
fatty liver in lipoatrophic diabetic 
A-ZIP transgenic mice. Diabetologia. 
2012;55:3350-3358. DOI: 10.1007/
s00125-012-2710-2
[116] Koeck ES, Iordanskaia T, Sevilla S, 
Ferrante SC, Hubal MJ, Freishtat RJ, 
et al. Adipocyte exosomes induce 
transforming growth factor beta 
pathway dysregulation in hepatocytes: 
A novel paradigm for obesity-related 
liver disease. The Journal of Surgical 
Research. 2014;192:268-275. DOI: 
10.1016/j.jss.2014.06.050
[117] Bala S, Csak T, Saha B, Zatsiorsky J, 
Kodys K, Catalano D, et al. The pro-
inflammatory effects of miR-155 
promote liver fibrosis and alcohol-
induced steatohepatitis. Journal of 
Hepatology. 2016;64:1378-1387. DOI: 
10.1016/j.jhep.2016.01.035
